US Patent Issued to Alexion Pharmaceuticals on March 31 for "Anti-ceruloplasmin antibodies and uses thereof" (Texas, Connecticut Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,977, issued on March 31, was assigned to Alexion Pharmaceuticals Inc. (Boston).

"Anti-ceruloplasmin antibodies and uses thereof" was invented by David George Potter (The Woodlands, Texas), Jennifer Ann Dzielawa (Montgomery, Texas), Brenda Sue Carter (Montgomery, Texas) and Mark Ma (Madison, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies which bind to ceruloplasmin and are useful for various applications, including detecting ceruloplasmin and immunocapturing ceruloplasmin in biological samples. The antibodies are useful in methods of measuring non-ceruloplasmin-bound copper concentrations and labile-bound copper ...